BioSignia is Other Healthcare Technology Systems in United States that focus on consumer health programs business. Founded in 1996. They cover business area such as developer, proprietary predictive modeling technology, healthcare, employee wellness, insurance, consumer health program, risk assessment program, individual, client, morbidity and mortality outcome, their associate cost impact, improved accuracy.
Other Healthcare Technology Systems
1996
( 28 years old in 2024 )
Consumer Health Programs
-
401 Harrison Oaks Boulevard
Suite 120
Cary, NC 27513
United States
Private
developerproprietary predictive modeling technologyhealthcareemployee wellnessinsuranceconsumer health programrisk assessment programindividualclientmorbidity and mortality outcometheir associate cost impactimproved accuracy
* We use standard office opening hours in near BioSignia's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
BioSignia is Other Healthcare Technology Systems business from United States that founded in 1996 (28 years old in 2024), BioSignia business is focusing on Consumer Health Programs.
BioSignia headquarter office and corporate office address is located in 401 Harrison Oaks Boulevard Suite 120 Cary, NC 27513 United States.
BioSignia was founded in United States.
In 2024, BioSignia is currently focus on consumer health programs sector.
Above is snippet of Google Trends for "consumer health programs" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with BioSignia, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
